# India exports to Belarus: Trade Route Risk | Yugalinks

Understand reported exports from India to Belarus, the product routes that need a closer look, and the conditions that may affect planning.

Canonical: https://www.yugalinks.com/trade/corridor/IND-BLR/risk

## Route overview

In 2024, India reported $70.7M in goods exports to Belarus. The overall review level is Watch.

## How to read this page

High attention means one or more conditions on these product types deserve a closer look. It is not a prediction that trade will stop or that a loss is certain. An HS6 code is the international six-digit code used to describe and compare traded goods.

## Key numbers

| Measure | Value | What it means |
| --- | ---: | --- |
| Latest reported exports | $70.7M | 2024 route total |
| Exports needing review | 19.1% | Share of route exports |
| Highest-priority products | 0 | Need the closest review |
| Products needing review | 6 | High-attention product types |
| Export volatility | 1 | Higher means bigger yearly swings |
| Below highest year | 33.8% | Compared with the route's best year |

## Product types to review

| Rank | HS6 | Product | Buyer-market imports | Below product high | Review level |
| ---: | --- | --- | ---: | ---: | --- |
| 1 | 300490 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $478.1M | 26.8% | Stable |
| 2 | 030499 | Fish: fish meat (whether or not minced) other than fillets, frozen, excluding swordfish (Xiphias gladius) and toothfish (Dissostichus spp.) | $19.4M | 53% | Watch |
| 3 | 300390 | Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $17.3M | 24.8% | High attention |
| 4 | 847989 | Machines and mechanical appliances: n.e.s. in item no. 8479.8, having individual functions | $109.2M | 0% | Watch |
| 5 | 851712 | Telephones for cellular networks or for other wireless networks | $465.9M | 46.6% | High attention |
| 6 | 300449 | Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $20.1M | 18.1% | Stable |
| 7 | 300320 | Medicaments: containing antibiotics other than penicillins, streptomycins and their derivatives, for therapeutic or prophylactic uses, (not in measured doses, not packaged for retail sale) | $11.2M | 33.4% | High attention |
| 8 | 300215 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $58.5M | 74% | High attention |
| 9 | 293399 | Heterocyclic compounds: n.e.c. in headings no. 2933 | $18.9M | 35.3% | High attention |
| 10 | 853690 | Electrical apparatus: n.e.s. in heading no. 8536, for switching or protecting electrical circuits, for a voltage not exceeding 1000 volts | $32.7M | 0% | High attention |

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-29). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.